Tuesday, 24 July 2018

Lilly plans Elanco IPO, posts quarterly profit above estimates

Eli Lilly and Co said on Tuesday it would take its Elanco animal health business public and posted a better-than-expected quarterly profit, helped by demand for its diabetes drugs Trulicity and Humalog.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)